Clinical Performance Evaluation and Cost-Effectiveness Analysis of miLab platform for Supporting Malaria Control in Target Countries (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/clinical-performance-evaluation-and-cost-effectiveness-analysis-of-milab-platform-for-supporting-malaria-control-in-target-countries
Noul Inc, a South Korean start-up, has developed the miLab(TM) platform, which allows automated sample preparation to imaging and AI analysis of small amounts of blood samples. The platform is of pote
Characterization of field malaria isolates and assessment of the impact of resistance profile on the transmission of resistant strains (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/characterization-of-field-malaria-isolates-and-assessment-of-the-impact-of-resistance-profile-on-the-transmission-of-resistant-strains
This is a joint research project between Swiss Tropical and Public Health Institute (SwissTPH, Switzerland) and Ifakara Health Institute (IHI, Tanzania). Malaria elimination is threatened by resistanc
Lufthygienische Dokumentationsstelle 2018-2021 (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/lufthygienische-dokumentationsstelle-2018-2021
Die vom Bundesamt für Umwelt (BAFU) finanzierte Dokumentationsstelle LUDOK am Schweizerischen Tropen und Public Health Institut (Swiss TPH) liefert seit 30 Jahren evidenzbasierte Informationen zu den
Efficacy and safety of fexinidazole in patients with Human African Trypanosomiasis (HAT) due to Trypanosoma brucei rhodesiense: a multicentre,... (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/efficacy-and-safety-of-fexinidazole-in-patients-with-human-african-trypanosomiasis-hat-due-to-trypanosoma-brucei-rhodesiense-a-multicentre-open-label-clinical-trial
A vector-borne parasitic illness, human African trypanosomiasis (HAT), also known as sleeping sickness, is usually fatal without treatment. The less prevalent form, T.b. rhodesiense (r-HAT), is concen
Evolution and Epidemiology of Rifampicin-Resistant Tuberculosis in Khayelitsha, Cape Town: Implications for Biology and Disease Control (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/evolution-and-epidemiology-of-rifampicin-resistant-tuberculosis-in-khayelitsha-cape-town-implications-for-biology-and-disease-control
Background Bacteria resistant to multiple antibiotics are a growing threat for global public health and the economy. Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB
Drug discovery and development for schistosomiasis: From repositioning of antimalarial drug leads and clinical advanced drug candidates to the... (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/drug-discovery-and-development-for-schistosomiasis-from-repositioning-of-antimalarial-drug-leads-and-clinical-advanced-drug-candidates-to-the-development-of-a-new-paediatric-formulation-of-praziquantel
The aim of my 4-year research project is to identify one or several antischistosomal drug development candidates targeting the haemoglobin degradation pathway and/or other mechanisms with favourable p
Analysing in-hospital mortality and morbidity in Côte d’Ivoire: implications for HIV/Aids, Malaria and TB (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/analysing-in-hospital-mortality-and-morbidity-in-cote-divoire-implications-for-hiv/aids-malaria-and-tb
sAnalysing routine data from health facilities across the country, the study intends to analyse trends in mortality and morbidity for HIV/Aids, Malaria and TB between 2010-2015. The Swiss TPH provides
Food security from the forest: the case of the commodification of baobab fruit (<em>Adansonia digitata </em>L.) in Boundou Region, Senegal (Publications)
Wild edible fruits from the forest have often been regarded as poverty food; however, there has been a notable shift in recent years as these wild edible fruits have gained increasing recognition for